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 Corporate Social Responsibility and Health are themes very dear to me. My academic 
background is related with the health sector, more specifically mental health. Therefore the 
opportunity to combine interest with past experience was very appealing to me. The 
organization analyzed in this dissertation, the Global Business Coalition on HIV/AIDS, 
Tuberculosis and Malaria; is closely related with these areas, combining both. The Coalition 
has been facing some financial constraints resulting from the global financial crisis. This fact 
makes it interesting from an academic and management perspective, in order to understand 
how a nonprofit can keep its sustainability; how it can adapt to a changing world with some 
strategic decisions that will foster its competitive advantage. Furthermore, the organization 





Corporate Social Responsibility (CSR) is already reckoned as important for companies, 
mostly due to public perception and consequently the impact on brand image. However, there 
has been an increasing tendency towards integrating CSR in companies’ strategy. Strategic CSR 
occurs when shared value is created, i.e. when both society and companies gain something. 
For companies, the premise of strategic CSR is gained benefits and it might even become a 
competitive advantage. 
Despite all the progress made in medicine the world is still facing important health 
problems and epidemics, which undermine not only human development but also economic 
growth and therefore affect businesses in multiple ways. Health should therefore be one of 
the issues addressed by CSR, particularly strategic CSR. The Global Business Coalition (GBC) is a 
nonprofit organization that brings businesses to the global fight against HIV/AIDS, tuberculosis 
and malaria, building on the private sector’s assets and expertise. As so, for companies GBC 
represents an investment in CSR, and it also is, or has the potential to be, a source of strategic 
CSR – aligning business interests with society’s health issues.  
GBC had been experiencing a consistent growth since its inception in 2001, however 
with the global financial crisis this tendency changed and GBC started facing important budget 
constraints. This study goes through the implications of this crisis to the Coalition, trying to 
understand not only the impact it has had but also what can be done to overcome the current 
difficulties and what can be expected in the future. The analysis shows that GBC is worth 
investing in for companies’ future sustainability; its business model is adequate though some 
small changes are suggested; it can render greater strategic significance for companies if 
slightly adapted; and its membership basis is expected to grow in the future. The case study 
also shows that GBC is already preparing to make some changes, in line with what is discussed 
in the analysis, in order to overcome the constraints posed by the current financial crisis. GBC 
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 The purpose of this thesis is to present the case of the nonprofit organization “Global 
Business Coalition on HIV/AIDS, Tuberculosis and Malaria” (GBC), which is currently 
undergoing significant internal changes in order to face the new challenges brought up by the 
recent global financial crisis.  
 The Coalition, which was launched in 2001, is a movement of businesses that are 
engaged in the fight against HIV/AIDS, tuberculosis and malaria by leveraging the assets and 
expertise of the private sector. The goal is to help terminate these diseases faster through high 
impact collective actions for a common cause. 
 This work tries to identify the Coalition’s main difficulties and suggest a set of actions 
to overcome them, taking into consideration GBC’s evolution until today, while trying to 
achieve long-term sustainability. It describes how the organization evolved, analyzes the 
actions taken by GBC in order to recover from adversity, and also analyzes other alternatives 
to regain and further improve its positioning and sustainability.  
 Therefore, the problem statement for this dissertation is: “The aim of this research is 
to understand the impact of the global financial crisis on GBC’s actions, structure and 
sustainability”. 
 In order to better structure the understanding of the problem statement and help 
solving it, some research questions were elaborated for guidance:  
 
1. Will GBC be able to maintain its membership basis? 
The purpose of this question is to understand how GBC’s membership was affected 
by the crisis and how it is likely to evolve in the future. This is an important issue 
given that the Coalition depends greatly on members’ fees to run its operations. 
 
2. To what extent was GBC’s budget affected and what was the resultant impact in 
terms of current/future programs and initiatives? 
The aim of this question is to understand whether and how GBC’s budget was 
affected and the direct consequences to the development and implementation of 





3. Will GBC be sustainable with its current business model? Will it have to change it? 
And is it worth it? 
The trends in memberships and budget following the crisis have direct implications 
to the continuity of the business model. This question is important because it 
analyzes its future viability and weights the pros and cons of keeping the current 
model or shifting to another. 
 
 The structure of this thesis is divided in five chapters. The present chapter introduces 
the master thesis and identifies the problem statement and research questions. The second 
chapter encompasses a literature review on the most relevant topics associated with the 
problem at hand; namely the relationship between health and economics, and the raising 
importance of corporate social responsibility for businesses in a world that has been 
increasingly devoting more attention to social issues. This theoretical overview will be the 
basis for the case study analysis and discussion. The third chapter presents the case study 
elaborated with the help of GBC staff. It includes an explanation of the context in which the 
organization operates, a thorough description of its characteristics, activities and strategy, and 
also the future path it wants to follow. The fourth chapter presents the teaching notes, 
intended to help teachers or students guide themselves in the analysis of the case. And, finally, 
the fifth chapter covers the major conclusions reached after completing this work (guided by 







II. LITERATURE REVIEW 
 
1. Health & Business 
 
1.1. Health, Human Development and Economic Growth 
 Health is perceived by humanity as a major asset, truly important and being regarded 
as the basis for a long and flourishing life (Aguayo-Rico et al., 2005; Sachs, 2001); economists 
on the other hand regard it to be, along with education, a determinant of “human capital” 
(Aguayo-Rico et al., 2005; Mexican Commission on Macroeconomics and Health, 2004), which 
is the driver for economic growth (Finlay, 2007; López-Casasnovas et al., 2005).  
 A healthy individual is not simply someone who does not present illness, it is someone 
who, in addition to that, is also physically, mentally and socially apt. Being healthy gives 
individuals the capacity to fully develop their intellectual, physical, social and emotional 
potential. Health allows individuals to be productive in their work, to be able to learn and to 
allocate their financial resources to other needs; therefore health is determinant for future 
income, wealth and consumption (Aguayo-Rico et al., 2005; Mexican Commission on 
Macroeconomics and Health, 2004; Sachs, 2001). 
 In the so-called intergenerational cycle (see Figure 2) child development in terms of 
health and education has implications in the adult future health, education and income. As an 
adult, these socioeconomic constraints will be passed on to the next generation, perpetuating 
the cycle in the absence of other incidents (Mayer-Foulkes, 2004; Mexican Commission on 
Macroeconomics and Health, 2004). 
 
Figure 1 – Intergenerational Cycle of Human Capital Formation 
 











 Indeed, health and poverty do seem to be linked, therefore by improving health one is 
also helping reduce poverty. As at the individual level, at the society level health is also strictly 
related with reduced poverty, economic growth and long-term economic development 
(Aguayo-Rico et al., 2005; Mexican Commission on Macroeconomics and Health, 2004; Sachs, 
2001). Robert Fogel (2002 cit. in Mayer-Foulkes, 2004; Mexican Commission on 
Macroeconomics and Health, 2004; Sachs, 2001) found a strong correlation between health 
and economic growth. His studies show that in the past two centuries Europe’s economic 
growth was enhanced by a decrease in mortality subsequent to an improvement in the diet 
and medicine related advances. Specifically, he attributes around 33% to 50% of England’s 
economic growth to these factors.  
 Further data shows that countries with better health indicators have greater economic 
growth and development (Pollara, 2009). Thus, not surprisingly, the poorest countries, in 
particular sub-Saharan Africa, are those most affected by diseases which consequently impede 
their economic growth and reduce their annual income.  (Sachs, 2001). Furthermore, disease 
has also much more striking economic consequences among the poor, for generally they rely 
much more on physical work (Mexican Commission on Macroeconomics and Health, 2004). 
The poor are also immensely more fustigated by communicable diseases, maternity mortality 
and malnutrition than the rich, vastly due to lack of access to proper living conditions, health 
care and information on prevention. As so, strategies for reducing the incidence of such 
diseases are also a way to reduce poverty (Aguayo-Rico et al., 2005; Sachs, 2001). Indeed, the 
health of the poorest billion people could be easily improved by addressing a small number of 
diseases that include HIV/AIDS, malaria, tuberculosis, maternal and perinatal conditions and 
malnutrition (Pollara, 2009; Sachs, 2001). Moreover, the Millennium Development Goals 
(MDGs) focus on both the reduction of poverty and specific health improvements (decrease in 
child and maternal mortality and in the incidence of HIV/AIDS, malaria and other major 
diseases) in order to take advantage of the existing connection and achieve better results 
(Sachs, 2001).   
 Cross-country studies also support the positive relationship between health and 
economic growth (Finlay, 2007; Sachs, 2001). When life expectancy at birth increases by 10% 
economic growth is also expected to increase by 0.3% to 0.4% per year.  High incidence of 
diseases like malaria and HIV/AIDS is also related to continuous and significant declines in 
economic growth rates. Even if AIDS did not affect GDP per capita, it would still have an effect 
on economic welfare for shortening longevity. Also, by 2015 AIDS is expected to cost a total of 
$22 billion with prevention, OI treatment and antiretroviral therapy. As for malaria, it is known 
to reduce economic growth in at least 1% per year (Sachs, 2001). Thus not surprisingly, a 10% 
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reduction in the number of malaria cases also leads to 0.3% annual growth increase (Gallup & 
Sachs 2000 cit. in Mexican Commission on Macroeconomics and Health, 2004). 
 Given the enormous impact that health has on economic development, investment in 
this area is crucial for an overall development strategy, particularly in low-income countries 
with high disease incidence (Sachs, 2001).  Although Sorkin (1977 cit. in Aguayo-Rico et al., 
2005), finds that health improvements in developed countries will have minimal consequences 
on economic growth, he ascertains that this is not the case in developing countries.  
 Figure 1 demonstrates how economic development depends on economic policies and 
institutions; and on aspects directly and indirectly affected by health, respectively human and 
enterprise capital, and technology. It also shows that health itself is influenced by economic 
policies and institutions and economic development both directly and indirectly, therefore 
highlighting its cyclical, interdependent nature. 
 




Source: Sachs (2001) 
 
 Disease hinders economic development mainly through (1) preventable diseases that 
reduce healthy life expectancy, (2) parents’ short investment in their children, and (3) 
undermining business returns and infrastructure investment. The first issue has to do with 
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preventable mortality and chronic disability that affect people of working age, resulting in the 
loss of billions of dollars every year. Point (2) accounts for the high rates of infant and child 
mortality that lead to higher fertility rates, as parents try to assure the survival of at least part 
of their offspring. Naturally this disables low-income families from properly investing in their 
children’s health and education. Data reveals that a decrease in child mortality is followed by a 
decrease in fertility rates and population growth, conducting to a higher average age – with an 
increased percentage of working age people GDP per capita also increases. Finally, the last 
topic concerns the counterproductive impact of disease in entire industries, either through 
workforce impairment (e.g. agriculture) or clients alienation (e.g. tourism); and relevant 
infrastructure projects (Sachs, 2001) 
 At the individual level, disease prevents economic security mainly due to (1) reduced 
market income because of medical care costs, loss of salary succeeding an illness episode, 
childhood disease hampering adult working ability (mentally or physically) and early death 
impeding future income; (2) shorter life expectancy; and (3) poor psychological welfare despite 
the absence of (1) and (2) (Sachs, 2001).  
 In terms of families and life cycle, an unhealthy individual can have a negative impact 
on family members’ development. A sick parent is less able to take care of his children, to 
teach and educate them, and will probably have more difficulty in providing financial support. 
As a result, children may be forced to start working, having to drop out of school (Sachs, 2001).  
 
 The private sector has thus an important role to play in this field, namely fostering 
R&D, for complementing government action which should include investments in health and 
education, law enforcement and environmental protection. These investments seem 
particularly important and potentially most effective given that 87% of child mortality (under 5 
years of age) is estimated to be avoidable, as well as 60% and 82% of mortality among males 
and females aged 5 to 29 correspondingly, and 69% female and 43% male mortality among 
individuals aged 30 to 69 (Sachs, 2001). 
 
1.2. Health and Business Sustainability 
 A society that has a high rate of disease has additional problems when it comes to 
managing business. An obvious problem has to do with the workforce. Apart from the negative 
impact on productivity, companies also have to deal with higher than usual workforce 
absenteeism and turnover. This impels companies to spend more time and money hiring and 
7 
 
training workers, with evident strong repercussions on their profitability (López-Casasnovas et 
al., 2005; Sachs, 2001).   
 High disease threat can also harm business sustainability from a client and investor 
perspective. Tropical parasitic diseases, as is the case of malaria, are a strong deterrent for 
tourism and otherwise lucrative investments, since they make regions unattractive for certain 
activities or even unlivable (Sachs, 2001). Ainsworth and Over (2004 cit. in Aguayo-Rico et al., 
2005) also state that AIDS affects domestic saving rates, reducing individuals buying power. 
 According to the World Economic Forum’s Executive Opinion Survey in 2004, 22% of 
business leaders say that malaria affects their business, with 10% revealing severe impacts. 
However, once focus is set in Sub-Saharan Africa these numbers rise to 72% acknowledging 
negative effects, with 39% revealing severe impacts (Bloom et al., 2006). 
 
1.3. Benefits from Improved Support 
 Macroeconomic Level 
 If key health interventions are implemented, in 2015 a total of 8 million deaths for 
infectious diseases and maternal conditions are expected to be avoided, implying at least 
direct economic savings of $186 billion per year. Considering that better health improves 
economic growth, as discussed above, then the benefits attributable to key health 
interventions would be much wider. When taking the two factors under consideration Sachs 
(2001) finds a value of no less than $360 billion per year in economic benefits, for the period 
between 2015 and 2020. 
 
 Business Level 
 By increasing the support given to fight diseases and improve health, companies get 
multiple benefits. One of them is having a healthy workforce, which prevents absenteeism and 
improves productivity. Also, if a worker's family member is ill, he will have increased 
responsibilities at home, which can lead to emotional burnout. Healthy workers also have 
better cognitive status, being better able to learn and teach. As abovementioned, health is 
positively related with education, which is of the utmost importance for business (Aguayo-Rico 
et al., 2005; Mexican Commission on Macroeconomics and Health, 2004; Sachs, 2001). In 
addition, socially responsible firms are better perceived by employees, helping to attract and 
retain local and global talent. Customers’ perception also plays a major role in their loyalty; the 
majority of consumers prefer socially responsible brands. And stakeholders expect companies’ 
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to contribute to societies where they operate, therefore earning their "license to operate"1. 
Furthermore, a firm’s social responsibility reputation can even improve stock performance, as 
suggested by evidence (Over, 1999). 
 
 “For-profit companies, nonprofit organizations, and social enterprises, along with 
insurers, providers, and manufacturers, already play an important role in providing health care 
to the region (sub-Saharan Africa). They account for as much as 50% of health care provision, 
and their role is growing” (International Finance Corporation 2007, p. vii). 
 
2. Corporate Social Responsibility 
 
2.1. The Rise of CSR 
 In the 19th century, long before the term corporate social responsibility (CSR) was 
widespread and turned into common terminology, business was already considered to have 
societal obligations. Some of the first known cases go back to the Industrial Revolution, when 
companies built housing for their workers, who would otherwise be likely to live in slums 
(Crawford, 1995). However, it was in the 20th century that CSR truly began to receive attention 
and the concept was developed. Important changes in the world, such as economic prosperity, 
and in the way of doing business were key factors in the shift towards CSR. With economic 
prosperity, having more money to spend, the level of interest in CSR seems to grow, while 
diminishing at times of recession (Smith, 2003). With globalization, the power of business 
escalated and it also became more pervasive. Companies operating in several countries had to 
adapt to very different realities in terms of living standards between host and home countries. 
Business started facing an ever-growing, unprecedented criticism, with worldwide reach. In the 
beginning of the 21st century, with new information technologies and increased media reach, 
several corporate scandals (Enron, WorldCom, Tyco) were made public, further damaging the 
business image (Dhiman, 2008; Porter & Kramer, 2006; Smith, 2003). As a result, society 
started demanding more from business and business action was also called upon to fill the gap 
left by governments, unable to meet certain social needs. Today, corporations are not only 
expected to correct their wrongs, but to take social responsibility to a higher engagement level 
as well. As a matter of fact, better or worse, many multinational corporations have embraced 
the challenge (Smith, 2003). Other factors contributing to this stepping up are therefore a 
greater than ever reputational vulnerability, due to increased visibility and a stronger public 





pressure brought upon them by third parties, namely NGOs. Reputation and brand image have 
become important market assets, as companies may be harmed if perceived by consumers as 
not socially responsible (Porter & Kramer, 2006; Spar & Mure, 2003). Thus, according to Porter 
& Kramer (2006) and Smith (2003), the reasons for CSR’s rise and current importance can be 
summarized in the following way: 
 
 Increased societal expectations publicly stated – License to operate 
 Reduction in governments’ power and scope 
 Globalization 
 Increased media reach resulting from progress in information technology - 
Reputation 
 Greater spread of democracy in the world 
 More government regulation demanding social responsibility reporting 
 
2.2. CSR Key Characteristics 
 CSR occurs when firms take actions that directly target furthering social goods, beyond 
their direct interests and what is required by law (McWilliams & Siegel, 2001 cit. in Doh & 
Guay, 2006). 
 The central idea in CSR is that business must work for improving social conditions, of 
society in general and stakeholders in particular (Doh & Guay, 2006; Smith, 2003). The 
underlying assumption to this current belief is the triple bottom-line sustainability imperative, 
which ascertains that companies should pursue sustainable development in three different 
dimensions: economic, social and environmental. CSR acts directly on social and 
environmental dimensions, which also impact the economic dimension (Dhiman, 2008; 
Henderson, 2009). In other words, CSR means a proper management of firms’ resources in 
order to guarantee an overall positive impact on society. 
 Porter & Kramer (2006) believe that CSR can offer gains that clearly surpass the costs. 
In his view, it can originate previously unimagined opportunities, innovation and turn into a 
competitive advantage. This means that CSR’s positive impact on society is also extended to 
the firm itself. 
 Depending on firms’ reasons to engage in CSR there are two distinctive motivations 
that can be drawn; the first is an intrinsic desire to help others - “normative case”, the second 
is based on self-interest – “business case”. The two cases are not mutually exclusive, meaning 




2.3. Strategic CSR 
 Companies and society are linked in an interdependent cycle – firms’ daily operations 
have an influence on society (inside-out linkages); external social conditions have an impact on 
firms (outside-in linkages). This means that business decisions and social policies can have a 
direct impact in each other. For that reason, they should be guided by the principle of shared 
value – mutually beneficial decisions. Companies and society must understand that a short-
term gain that puts the other at risk will necessarily have long-term negative consequences on 
both. To be able to take advantage from this principle, companies must guide their strategy 
based on a social perspective of its repercussions. They should only engage in CSR activities 
that allow the creation of shared value. Certain social issues will prove to have a significantly 
larger effect on a firm’s competitiveness, providing good opportunities for strategic CSR 
activities (Porter & Kramer, 2006). Figure 3 provides information on how to differentiate 
between social issues that have and have not a direct impact on companies’ performance, and 
which therefore justify, or not, companies’ action. 
 
Figure 3 – Prioritizing Social Issues 
 




Social issues that 
are not significantly 
affected by a 
company’s 
operations nor 









affected by a 
company’s 
activities in the 
ordinary course 
of business. 
Social Dimensions of 
Competitive Context 
 
Social issues in the 
external environment 
that significantly 
affect the underlying 
drivers of a 
company’s 
competitiveness in 
the locations where it 
operates. 
 
Source: Porter & Kramer (2006) 
 
 Companies must sort social issues into one of these three categories for each of their 
business units and locations, since they may differ accordingly, and afterwards evaluate them 
in terms of potential impact to society and the company. The results from such analysis should 
support the creation of a corporate social agenda, where CSR initiatives are clearly defined 
(Porter & Kramer, 2006). Smith (2003) believes this, the development of a CSR plan consistent 
with companies’ strategic objectives, is undoubtedly one of their biggest challenges. 
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 The corporate social agenda, as Porter & Kramer (2006) propose it, should be mainly 
composed of strategic CSR initiatives, rather than responsive CSR ones (see Figure 4 - 
Corporate Involvement in Society: A Strategic Approach). Responsive CSR can be described as a 
more basic, less ambitious approach. It comprises only acting as a good corporate citizen and 
mitigating the adverse effects generated by companies’ activities. Strategic CSR, on the other 
hand, is far more ambitious, it is not about quantity but instead key actions that render the 
most significant benefits. Strategic CSR aspires to create maximum shared value, and relies on 
initiatives that comprise both inside-out and outside-in dimensions in order to be able to 
achieve it (Porter and Kramer, 2006).  
 
Figure 4 – Corporate Involvement in Society: A Strategic Approach 
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capabilities to improve 







Source: Porter & Kramer (2006) 
 
 In conclusion, companies should identify the social issues with which they are more 
closely related, for which their capabilities are most adequate and from which they can get 
competitive benefits. To create a unique positioning and distance themselves from 
competitors companies must be proactive and coherent, developing CSR initiatives in 
agreement with their strategy (Porter & Kramer, 2006). In a similar perspective, Smith (2003) 
points out that given the high competitiveness evident in the current world, at the margin, CSR 






 The social agenda is sought by various entities. Although when talking about the 
private sector our minds go straight to corporations, it includes all activities controlled by 
someone other than the state, including charitable foundations. These foundations and 
individual donors are a part of philanthropy, which is regarded with the idea of doing good by 
providing financial support to social enterprises (Porter & Kramer, 1999). Social enterprises 
develop innovative ideas with a social goal and can belong to the for-profit sector (e.g. social-
purpose commercial ventures, corporate social entrepreneurship); to the nonprofit sector or 
even to hybrid structures of the two (Austin et al., 2006). 
 Comparing philanthropy agents, the reach of individual donors and foundations is 
substantially different. Foundations, which are funded by donors, can more effectively create 
societal benefits because they have the scale, time-horizon and professional management that 
individual donors cannot have. However, most foundations do not provide non-financial 
resources, neither do they measure performance because they consider it to be out of their 
scope and responsibility. Performance measurement can be hold as an undesired burden, 
especially to those whose motivations rely mainly on tax benefits. Therefore it is only natural 
that most foundations’ work relies solely in giving money, and few are the ones who provide 
social services themselves (Porter & Kramer, 1999). 
 Philanthropy creates values when the social benefits they produce “go beyond the 
mere purchasing power of their grants” (Porter & Kramer 1999, p. 123). These authors suggest 
four different successive approaches for creating value and sort it by the ascending resource 
leverage they create – impact shifts from the single grant recipient to an entire field. The four 
approaches, by ascending value creation, are: 
I. Selecting the best grantees – Each dollar will earn more social return than if given by a 
less informed donor, performance measurement plays a central role; 
II. Signaling other funders – By attracting third parties they are able to improve the 
return on a larger pool of philanthropic assets; 
III. Improving the performance of grant recipients – Foundations become engaged 
partners by helping to improve grantees’ capabilities, which improves their 
effectiveness leading to higher returns on money spent; 
IV. Advancing the state of the knowledge and practice – New frameworks can arise by 
funding research and a systematic progression of projects that create more effective 




 Philanthropy’s future directions should therefore be towards a more strategic and 
engaged approach, sometimes called engaged philanthropy or venture philanthropy. This 
strongly rising idea of philanthropy assumes a long-term high level of engagement in the 
grantee’s organization, providing skills and services instead of only financial support (John, 
2006). 
 
2.5. Nonprofit Organizations 
 A nonprofit is an organization that does not distribute its surplus funds to owners or 
shareholders, it invests them in order to achieve its objectives. Governments and government 
agencies are not considered to be nonprofits (Grobman, 2008). 
 A study conducted by Arenas et al. (2009) found that NGOs, for instance, are perceived 
as being key players in CSR but their role is also considered to be controversial and their 
legitimacy contested. For that reason, nonprofits should pay attention to the image they pass 
and to people’s perception, since it can undermine their work. Particularly important to this 
matter is the relationships established with businesses, which can improve of deteriorate their 
accomplishments. 
 The impact of activism is still an understudied issue, however recently more studies 
have been carried out and the results suggest that it has a strong impact on firms. The 
pressure felt by firms seems to oblige them to respond and take action; they reckon that public 
protest can change consumer preference. More research is needed to understand activism’s 
impact in more quantitative terms (Spar & Mure, 2003).  
 The traditional nonprofit model is one of “dependency”, usually relying on 
philanthropy, voluntarism and government subsidy (Boschee & McClurg, 2003; Elkington & 
Hartigan, 2008). A nonprofit will only be sustainable and self-sufficient if it generates earned 
income from its activities. But there are some differences. Sustainability can be achieved by 
combining earned revenue with the traditional model, while self-sufficiency, which is clearly 
more ambitious, requires relying solely on earned revenue (Boschee & McClurg, 2003). 
 Leading social enterprises follow one of the three business models described next. The 
“leverage nonprofit” model refers to ventures that provide public goods2 to people 
economically vulnerable and at the same time allow them to assume ownership of the 
initiative, hence improving its long-term sustainability. The organization is still supported 
financially, politically and in kind by external partners. This model is followed for example by 
the Barefoot College. In the “hybrid nonprofit” model, similarly to the previous one, public 
                                                          
2  A public good is one whose consumption by an individual does not reduce the amount available for 
consumption by others. 
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goods are provided to those economically vulnerable but the idea of making money and 
reinvesting it exists. As so, at least part of the costs can be recovered by selling goods or 
services. Funds from public, private and philanthropic organizations can still be mobilized. The 
Aravind Eye Care System is an example of this model. The “social business” model is 
characterized by being for-profit but focusing on social missions, as happens with the 
enterprise La Fageda. The profits made are destined to support the poor and reinvestment to 
grow the venture. Investors do not simply give funding but actually seek both financial and 
social returns (Elkington & Hartigan, 2008). 
 The latter model can have unprecedented gains but it also has downsides, such as 
difficulty in surviving if they do not become profitable. Therefore many nonprofits are not 
interested in changing to being for-profits, nor is it their aspiration (Elkington & Hartigan, 
2008).  
 
2.6. The Case for CSR 
 Bad practices by companies sometimes negatively impact their economic 
performance. For example, the well-known American retail chain Wal-Mart accused of putting 
small retailers out of business, not providing fair compensation for their workers and suppliers, 
among other things. Consumers’ reactions led to an estimated loss of 8% in market share. 
Contrarily, companies committed to CSR are expected to have higher revenues, more satisfied 
employees and consumer and greater productivity (Dhiman, 2008). One example is the 
multinational Starbucks, with a three times lower than average employee turnover the 
company has managed to reduce the corresponding costs, thus improving economic 
performance. Starbucks low employee turnover has to do with its socially responsible practices 
being positively perceived between the staff. Studies prove that employees prefer to work for 
more socially responsible companies and are also more likely to start good word of mouth 
when this happens (Smith, 2003). 
 When CSR joins different entities that show concern for the same social issue, through 
cooperation and collective action their initiatives become more powerful, further improving 
their results (Porter & Kramer, 2006). 
 Finally, having either a direct or indirect impact in economic efficiencies (Smith, 2003), 
sustainability seems to lead to profitability, innovation and growth (Dhiman, 2008). Smith 
(2007, p. 186) actually states that “the prolonged advantage of corporate social responsibility 





2.7. The Case against CSR 
 As stated above, one of the main drivers for CSR is society’s expectations. This has to 
be considered with proper care, since not always are these expectations reasonable and well-
substantiated. When this is the case, companies should distance themselves to avoid the 
pitfalls of entering in areas that are out of their scope and ability (Henderson, 2009). 
 Some people argue that CSR might make managers lose focus from what is truly 
important to reach desired economic performance, therefore impairing performance in 
addition to increasing costs – profits are jeopardized. They even consider that the impact of 
firms’ CSR activities in social well-being is not necessarily positive (Henderson, 2009; Smith, 
2003).  
 Another important stand when advocating against CSR is the over-regulation bias. For 
instance, imposing uniform environmental or social norms and standards regardless of each 
country’s specific features can have a powerful detrimental effect in trade and investment 
flows (Henderson, 2009).  
 One thing that is not so much against CSR but more not pro CSR is the lack of strong 
supportive data. One of the major problems with CSR is precisely the lack of reliable studies 
and evidence showing the financial value of its initiatives (Dhiman, 2008). Measuring the 
effectiveness of CSR is still a somewhat disregarded matter, especially in what concerns to its 
more quantitative, financial, return.  Developing measures that adequately measure social and 
environmental performance should be a future target. Another issue has to do with 
inappropriate allocation of resources, some firms spend more money in advertizing for their 
social initiatives than in the initiatives themselves (Smith, 2003). 
 As Henderson (2009, p.15) puts it, “businesses do not aim to further economic 






Even though part of the information present in the case study was retrieved from 
public sources, such as GBC’s website and others referenced in the case study; a great part of 
the information collected was provided directly by GBC, not being publicly available at the 
moment. 
Interviews were held with GBC’s Vice President for Membership and Advisory Services, 
Pamela Bolton, who clarified any doubts regarding the company and its activities, provided 
data and documents. The interviews were carried out through Skype, given that GBC’s head 
office location is in New York, USA.  
The case study is therefore based in information retrieved from these various sources, 
but mostly on what was shared by GBC.  
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IV. CASE STUDY - The Global Business Coalition: A Decade of Bold 
Leadership 
 
   
 
Case Introduction  
 
In the turning of the century the number of AIDS related deaths had finally begun to 
decline in developed countries as a result of new drug treatments3. However, in developing 
countries, those that are most affected by disease, very few people had access to the new HIV 
treatments, that due to patents were simply too expensive to afford.  
When the Global Business Coalition first started in 2001, business was doing relatively 
little on HIV/AIDS (its sole focus until 2006), despite of its clear impact on world economy. 
Many companies did not have policies around HIV, as for instance nondiscrimination, access to 
education or care.  In the last 10 years, however, there has been great progress in the fight 
against HIV/AIDS, malaria and tuberculosis.  Today, many companies look at health from a 
more comprehensive perspective, and even GBC will soon be expanding its mandate. 
 GBC has its share of responsibility in the progress made in the last decade. “The 
Coalition is a movement of businesses that bring private sector assets and expertise to the 
global fight against HIV/AIDS, tuberculosis and malaria. By joining forces with governments, 
international agencies and nonprofits, the Coalition will reach more people, more quickly, 
more effectively”4. GBC wants to help ending these diseases more rapidly through collective 
actions for a common cause, which have the ability to achieve greater impact. GBC guides 
companies through projects where the use of their core competencies can maximize impact, 
furthermore the Coalition shares knowledge and best practices. 
 
                                                          
3
 http://www.avert.org/AIDS-timeline.htm  
4 Bolton, P. (2010). How the private sector is speeding global progress toward MDG 6. Millennium 
Development Goals Review, Oct, p. 20-21. 
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HIV/AIDS, Malaria & TB  
 
HIV/AIDS 
 According to UNAIDS (United Nations Programme on HIV/AIDS), in 2009 there were 
2.6 million new HIV infections, this corresponds to 21% fewer cases than in 1997, when the 
number of new infections peaked. However, in some countries the number of new infections 
has increased more than 25%.  
 Globally, the number of AIDS-related deaths has decreased, from 2.1 million deaths in 
2004 (maximum ever) to about 1.8 million in 2009 (72% of which in sub-Saharan Africa). In 
total, since its discovery, more than 25 million people have died from AIDS.  
 According to UNAIDS, in 2009 33.3 million people lived with HIV. According to GBC 2 
million people are expected to die this year for lack of access to treatment. The majority of 
those infected are of working age, making business directly related to them, for being either 
employees or their relatives. Business accountability can also be extended to the communities 
where it operates and their stakeholders. 
 Whichever way, business has definitely a major role in fighting HIV/AIDS. For every 
Coalition member, the motivation comes not only from saving lives, but also from protecting 
their interests by protecting their employees and their families, attracting and retaining talent 
and earning their social license to operate. Some companies might even find new 
opportunities in markets at the bottom of the pyramid.  
 
Malaria 
 Although malaria is a preventable and curable disease, in 2009 there were still 225 
million cases and 781,000 deaths caused by the disease. However, this represents a clear 
improvement compared with the 244 million cases in 2005 and the 985,000 deaths in 2000. 
Africa had the largest absolute decline in deaths. 
 According to GBC malaria is a major threat to global health and economic welfare, it is 
responsible for employee absenteeism hence affecting productivity. The major challenges to 
fighting malaria are lack of resources and effectively implementing control activities, treatment 
and R&D. Business action is thus crucial in this fight, having the ability to go beyond bed nets 







 In 2009 there were 9.4 million new TB cases and close to 2 million deaths. In absolute 
terms TB incidence is actually increasing while in relative terms it is decreasing about 1% each 
year.  
 TB is strongly related with HIV, individuals with HIV account for over 10% of TB cases 
every year and are much more likely to develop TB than those HIV-negative.  
 In addition, each year about 0.5 million cases are multidrug-resistant TB (MDR-TB), this 
form of TB has been increasing and has lower cure rates, between 50% and 70%.  
 TB’s impact on business is huge, the World Economic Forum estimates a resultant loss 
of $16 billion in countries’ annual incomes. Much like HIV/AIDS and malaria, TB leads to 
absenteeism, high health insurance costs and reduced productivity. 
 
 For further data on these three diseases please see Exhibit 1 - Information on 
HIV/AIDS, Malaria & TB. Exhibits 2 to 5 provide data on these diseases from a geographical 
perspective of the world. 
 
The Global Business Coalition 
 
History  
In 1997, at the World Economic Forum annual meeting in Switzerland (the biggest 
gathering of economic and political dignitaries), Nelson Mandela condemned political leaders 
for their scarce efforts against the AIDS pandemic and, together with the head of UNAIDS and 
the chairman of Glaxo Wellcome, called for the business community active action on the fight 
against HIV/AIDS5. In response to the appeal, 17 companies stepped up and formed the 
nonprofit Global Business Council.  
 In 2001, UN Secretary General, Kofi Annan, stated the United Nations commitment to 
fighting global epidemics and appealed to a broader and deeper business engagement. In 
September of that same year, after leaving the position of U.S. Ambassador to the UN, Richard 
Holbrooke re-launched the Global Business Council as a Coalition with support from the UN 
Foundation, UNAIDS, and philanthropists Bill Gates (Gates Foundation), George Soros and Ted 
Turner. The organization’s network grew considerably, reaching the milestone of 100 member 
companies. 
                                                          
5
Based on information sent by GBC staff and retrieved from www.ncbi.nlm.nih.gov/pubmed/12321752. 
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 Presently, lead by CEO John Tedstrom, GBC comprises over 200 members among 
corporate and non-corporate partners, including 26% of Fortune 100 and 28% of Global 100 
companies. The Coalition expansion model now includes captivating global health players and 
medium size enterprises. Furthermore, in 2010 GBC membership was expanded to include 
leading international NGOs. This decision was made based on the opportunities these leading 
organizations represented in terms of establishing knowledge, providing technical guidance 
and on-the-ground assistance to corporate members operating in endemic regions. 
 
Mission 
 The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria’s raison d’être is 
to mobilize the power of the global business community in order to fight the HIV/AIDS, 
Tuberculosis and Malaria epidemics.  
 
Values6 
 In 2010 GBC set the following Guiding Principles: 
1. Collective servicing; 
2. Everything will have multiple value; 
3. Everything will have specified, concrete outcomes; 
4. Efficient and effective project management; 
5. Consistently strengthen the GBC brand; 
6. Build culture of accountability. 
 
Objectives7 
 In order to fulfill its mission, GBC pursuits the following goals: 
 Build coordinated capacity to fight global epidemics, such as HIV/AIDS, Tuberculosis 
and Malaria; 
 Promote innovation in global health, by leveraging the core competencies of its 
business partners; 
 Raise companies’ awareness and engagement in promoting global health, by 
strengthening policies and resources; 
 Increase access to prevention, treatment and care through the implementation of 
programs in the community and workplace; 
                                                          
6 Based on documents sent by GBC staff 
7
 Based on documents sent by GBC staff 
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 Share research and educational content in order to help improve the results of 
companies’ global health programs; 
 Provide external recognition and third-party validation for the private sector’s health 
programs and investments. 
 
 In addition to these objectives, in 2011 the Coalition has also set a number of top 
priorities. These are, one can say, more internally directed and are as follows: 
1. Exceed revenue targets and end 2011 with a surplus 
2. Strengthen GBC’s brand through excellent delivery on current commitments that 
keeps core members engaged 
3. Confident, professional introductions and execution of mandate that attracts new 
members and revenues 
4. Focus ruthlessly on our key core competencies:  
- Convene and mobilize members, partners, governments, for high-impact 
partnerships 
- Provide recognition and visibility to members to outside stakeholders, 
governments and employees 
- Spread best practices throughout the Coalition 
- Represent business in key settings 
5. Continue to build Board and Corporate Advisory Board 
 
Strategy and Business Model 
 GBC fulfills its mission and goals by playing a central role in the guidance and advisory 
of the business sector towards actively and effectively promoting global health. It links 
different organizations; it assures the creation of public-private partnerships and the 
coordination of their efforts, this way accomplishing more positive outcomes. Moreover, GBC 
decides which global health issues are in greater need of their support and action, once these 
are defined, it seeks corporate collaboration among the companies that present the most 
suited core competencies to deal with the problem at hand and helps allocating their 
resources. In other words, the Coalition develops high-impact collective actions for currently 
unmet needs, by bringing together and coordinating companies, nonprofits and governments. 
 GBC offers companies different types of services, apart from those stated above, the 
Coalition also develops smaller scale activities. For instance contributing with its expertise for 
the creation and implementation of workplace disease prevention programs; supporting 
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companies’ self-evaluation and assessment of improvement opportunities; providing guidance 
for case studies and sample strategies. 
 When comparing GBC’s early beginning to the work developed today, a shift can be 
perceived in its action. While before GBC was more focused on providing technical support and 
guidance, today its focus is set more on networking activities for companies and NGOs, raising 
awareness to companies’ projects. 
 
 GBC is a membership organization, with most revenue in the form of dues paid by 
member companies and other organizations. Currently there are two types of membership: 
Premier members who pay $30,000 per year and have access to an account manager, and 
affiliates who pay $5,000 per year and follow a self-service model. Other important sources of 
revenue are grants and special events (e.g.: annual conference). The majority of this money is 
channeled to program services and the rest to supporting services, including fundraising.  
 Until 2008 both GBC’s revenues and expenses were steadily increasing, however in 
2009, with the global financial crisis, there was a significant decrease in revenue (memberships 
dropped; USAID funding cut substantially), which led also to a significant cut in the Coalition’s 
expenses (see Exhibit 6 - Key Financials). 
 
Strengths 
 For ten years GBC has been developing and perfecting its own core competencies and 
strengths. The Coalition is unevenly positioned to establish relationships, to promote and 
support business action and partnerships. It has become expert in actively seeking and 
addressing the most critic health related issues in various ways, such as: 
 Finding, generating and managing engagement opportunities; 
 Creating a network of non-corporate partners and supporters; 
 Promoting and defending good government policies; 
 Developing the capacity of businesses; 
 Leading companies to projects where their impact can be maximized. 
 
Organizational structure  
 Crucial to the triumph of any organization is, among core competencies and strategy, 
the excellence of its leaders and how they structure the organization. The way organization’s 
mechanisms are set in action, how information flows within the organization and decision 
power is distributed, can have either a positive, neutral or negative impact on the outcomes of 
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their activities. GBC has chosen a fairly simple structure, on top we have the Board of 
Directors, assisted by the Corporate Advisory Board and, finally, supported by the Global 
Leadership Team. 
 The Board of Directors currently consists of eight people, between co-chairmen, 
directors and a president & CEO; however the number of Board members can range between 
one and twenty. With the exception of GBC’s president & CEO, all other Board members are 
leaders of member companies. These meet at least once a year and GBC requires a minimum 
of one third of the Board for validation of decision making. The Coalition also discloses the 
salaries of the Board members, in order to assure transparency and credibility. 
 The Corporate Advisory Board plays the role of advising GBC on the strategic direction 
to follow in leading the business fight against global epidemics. Currently there are sixteen 
members in the Corporate Advisory Board, representing member companies and reflecting 
their geographical and sectoral diversity. The Advisory Board’s members are either the Chief 
Executive or Chairman of member companies who are directly invited by GBC’s President. 
However, the Advisory Board might also have representatives of companies that directly 
applied to the job by contacting GBC’s office in New York. 
 The Global Leadership Team, actual GBC staff, develops and implements the work that 
sustains the organization. It is divided in several offices according to the field of expertise, 
namely Strategy & Regional Affairs; Finance, Legal and Operations; and Membership & 
Advisory Services, which includes two others – Communications and Impact Initiatives (See 
Exhibit 7 – GBC Organizational Structure). 
 
Global presence  
 Although GBC’s headquarters are in New York (USA) the Coalition has several other 
offices around the world, being each one of them responsible for serving and managing 
members within its geographic region. Nonetheless, the Coalition is a global team and 
therefore all offices join their forces and work together towards the same goals, thus 
maximizing their resources and improving performance.  
 Currently, GBC is organized in geographic regions and corresponding offices, which are 
as follows: 
- GBC Russia: Moscow – Responsible for Russian Federation and the Commonwealth of 
Independent States; 
- GBC China: Beijing – Responsible for China and East Asia; 
- GBC East & Central Africa: Nairobi – Responsible for Central Africa and Middle East; 
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- GBC Southern Africa: Johannesburg – Responsible for Southern Africa. 
 
 Following the cuts from USAID funding that supported the Russian and Ukraine 
programs, GBC closed its office in Kyiv. Recently it also closed its European office in Paris and 
established a strategic alliance with the European social enterprise Local InSight Global Impact. 
This strategic partnership increases the capacity for broad impact by leveraging business skills. 
As a result of the offices closure, current member accounts are now managed by staff located 
in New York. 
 
Memberships 
 GBC has chosen a membership base with the purpose of creating an extensive network 
of both corporate and non-corporate partners. Since its inception, GBC members came from 
different backgrounds (location, industry, size). Originally there were 17 member companies 
and currently, as of April 2011, GBC has 226 members (See Exhibit 8 - Members by Industry 
and Region 2001/2011) distributed over five continents (See Exhibit 9 - GBC Member 
Companies by HQ location). These companies are involved in a variety of matters that range 
from agriculture to financial/bank/insurance as well as healthcare/medical. This diversity 
allows the exploration of very different core competencies and a wider number of synergies 
for its collaborative actions programs. Some of the resources members may contribute with 
are: 
 Planning, management, marketing and/or financial expertise and assistance;  
 Experienced and dedicated experts for specific projects;  
 Preventive and curative medical services (for employees, families, communities), 
whether directly provided or subsidized; 
 Infrastructure, namely distribution channels; 
 Access to employees and customers; 
 Strong local, national and global brand power;  
 Marketing and communication channels; 
 Relationships with suppliers, governments and other businesses; 
 In-kind contributions of products and other resources. 
 
 For companies committed in promoting global health, by being a GBC member they 
have the opportunity to improve their effectiveness and performance in a well-designed and 
cost-effective way - GBC helps members getting focus and finding partners.  
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 For non-corporate members, GBC’s most important role is to bring together players, 
resources and capabilities, hence leveraging public-private partnerships. Partnerships are one-
to-one joint ventures based on collective action and cost-sharing. For instance, a company 
might contract with an NGO for specific advice or services, thus the relationship established is 
one of purchasing between only one company and one NGO. 
 
 Though not all members are actively fighting diseases in the field, each one of them 
wants to contribute to global health. Therefore, “to be a coalition member is to support 
strategies that bring businesses, civil society, and governments together in common cause” (in 
www.gbcimpact.com, 15th April 2011). 
 
Setting initiatives  
 GBC offers a range of services, including helping companies implementing strong 
workplace policies and programs and expanding them into the broader community. However, 
at times, the Coalition undertakes an “initiative”, which can be described as a major effort such 
as an event or collective action. Initiatives are usually developed with several objectives in 
mind, including expected member demand.  
 Acknowledging that certain types of challenges can be better coped with collective 
action, GBC also offers what it calls “Impact Initiatives”. Impact Initiatives move companies 
from unilateral to multilateral action. Sharing a common objective these companies form 
global work teams which are cross-functional and differ on characteristics such as being public 
or private, global or local. 
 Impact Initiatives undergo several stages of development. The first stage is, obviously, 
the idea generation, which might come from companies, partners or GBC staff and must fulfill 
three key criteria: 
1. Meet one of GBC’s five strategic priorities (workplace policies, supply chain, media and 
public awareness, sustainable funding sources, health care systems); 
2. Its potential for major impact is boosted by collective action; 
3. Be sustainable and long-lasting. 
 
 The next stage is followed by an assessment of the needs, opportunities and potential 
partners, which is done by GBC staff. Once partners are defined (action team), they work with 
GBC in order to determine the extent of their action. An initial meeting to define roles and 
responsibilities is arranged with leading member companies, partners and government 
representatives. The action team then identifies needs and searches for partners who can 
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effectively sort them out and a business plan is made. The team (businesses and partners) 
works together to guarantee proper implementation and success of the defined plan. While 
the initiative is executed assessments are made, allowing for the recognition of progress made 
and of arising needs and opportunities. Finally, GBC will make communications based on the 
knowledge and insights brought up during the Impact Initiative that can maximize the 
effectiveness of the global fight. Furthermore, communicating the progress and impact 
achieved will also help raising awareness to the importance of business and partnerships in the 
fight for global health. 
 Despite what was described above, most Impact Initiatives are not based on member 
demand but mainly developed by GBC. This has to do with companies’ specific objectives, 
which may differ from GBC’s. The Coalition’s objective is to get more input from companies, 
but also acknowledges that, to a certain degree, it may not be a realistic expectation. 
 
Current programs   
 GBC’s current programmatic agenda can be divided into three main groups: Impact 
Initiatives, Working Groups and Events. Five Impact Initiatives are currently ongoing in Russia, 
China, Kenya and the United States. These impact initiatives are: 
- Russian Media Partnership8:  Reaching people with critical HIV/AIDS messages; 
- China HIV/AIDS Media Partnership (CHAMP): Awareness campaign that so far has 
reached over 670 million Chinese ; 
- Health at Home/Kenya: Home-based HIV Testing expected to reach over 1 million 
people; 
- Collective Action Against AIDS in the USA: Hairdressers trained to educate 100 million 
about HIV/AIDS; enabling millions of consumers and employees to find HIV testing 
resources; bringing corporate voices to Capitol Hill to improve key policies; 
- Healthy Women, Healthy Economies - Private-Public Partnerships on Women and 
Girls: Investing in women’s and girls’ health and on their economic empowerment, 
education, involving men and boys, and reducing gender-based violence. As part of 
this impact initiative, a new initiative to improve gender equity through male 
workforce engagement will begin in June 2011. It is expected that the initial founding 
group reaches a minimum of 100,000 men, growing throughout the two years of the 
Healthy Women, Healthy Economies initiative. The importance of this action grounds 
                                                          
8
 A media partnership integrates different business expertise, such as in consumer market research, 
design, government relations, news coverage and media production; in order to better reach its target 
and prevent the dissemination of HIV. 
27 
 
on the gender-based external pressures men face to act in certain ways that reveal to 
be inappropriate and which undermine the health of their family, friends, co-workers 
and virtually every female that interacts with them, in addition to their own. Examples 
include gender-based violence and HIV. 
 
Working groups, which are based on specific topics, join competitors and other 
stakeholders, as for instance suppliers. These groups cooperate to set specific lines of action 
and to create the necessary tools for achieving common objectives. The existing working 
groups are Next Generation Strategies, Travel & Tourism, Oil & Gas, Bed Net Industry Dialogue, 
Private Sector Delegation to the Global Fund, and Corporate Alliance on Malaria in Africa 
(CAMA). 
 Lastly, current events include Corporate Connection calls with Global Fund, UNAIDS & 
US Global AIDS Coordinator; Members Meetings with USA Department of State, White House 
Office for National AIDS Policy, UNAIDS; Regional Members’ Forums in Europe, Asia and Africa; 
Technical workshops in Ghana, Kenya, Russia and Ukraine; White House Public-Private 
Partnership Meeting for Selected Members; 1,500 corporate, government and nonprofit 
personnel trained at GBC workshops; and finally, CAMA Entomology workshops in West Africa. 
 
Results so far  
 By 2010 the Coalition has reached 1 million people through members’ workplace 
programs for HIV, TB and Malaria. GBC has also established Public Private Partnership 
engagements with 7 national governments (Angola, China, Ghana, Kenya, Russia, South Africa, 
U.S.A.). 
 AIDS: 116 CEOs have already signed the Coalition’s HIV/AIDS non-discrimination 
pledge, covering a total of 5,000,000 employees with this declaration. CHAMPS’ public service 
announcements (PSAs) with movie stars alerting for AIDS prevention and stigma reached 
750,000 Chinese, and GBC’s Russia Media Partnership drove 30 million Russians to use 
protection, preventing AIDS. Furthermore, GBC gave antiretroviral treatment to 2.8 million 
people with AIDS, mother-to-child HIV transmission prevention treatment to 930,000 HIV-
positive pregnant women, basic care and support services to 4.9 million orphans and other 
children affected by AIDS.  
Malaria: An assessment of GBC's 2007 malaria partnership in Zambia demonstrated 
that the distribution of 500,000 bed nets prevented 130,000 child malaria cases. Moreover, 
through GBC’s supported programs 122 million nets were distributed, 108 million malaria 
cases were treated and home indoor residual spraying was made over 19 million times. And on 
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the aftermath of the bed net dialogue (focused on finding an efficient bed net procurement 
system), global bed net delivery can now be made 6 months sooner as a result of agreements 
made. 
Tuberculosis: The Eli Lilly MDR-TB Partnership, a member intervention supported by GBC, by 
2009 had given treatment access for nearly 50,000 patients worldwide. Public awareness and 
antistigma campaigns made with the help of Red Cross in Kazakhstan, Romania, South Africa 
and Uzbekistan reached more than 15,000 people. In another intervention, the Chevron 
Corporation tested 1,884 patients for TB in Angola, resulting in 539 positive TB diagnoses. A 
97% cure rate was achieved among the ones who received treatment. 
 
Measuring Performance and Impact 
 Though evaluation is regarded as an important issue, for guiding future actions, it is 
also acknowledged as a difficult effort. The Coalition is therefore not always able to assess 
companies’ and its own programs as thoroughly as desired, mostly due to limited power, 
resources and inherent costs. Since GBC creates and develops programs but is not an 
implementing organization itself (members are the ones who implement them), it does not 
have the power to demand companies to evaluate their actions and present the results.  
 However, GBC makes sure to at least assess companies’ projects and their impact 
through their annual awards competition. Companies that wish to apply fill an application form 
with a set of criteria which is then evaluated by a jury. The jury is formed by external judges 
drawn from four groups - last year’s winners; business people (experts in member companies); 
representatives of government and multi-lateral organizations (e.g.: Global Fund, US Agency 
for International Development); experts from NGOs, academia and foundations. The awards 
are given based on business involvement under four categories:  Workplace/workforce; 
Community (often an extension of initiatives for the workplace); Core Competence (where 
companies apply their skills, resources, networks and so on, to address global health 
challenges); and Advocacy/Leadership (companies that make their voices heard on behalf of 
important health issues or challenges). 
  Some of GBC’s original members have progressed immensely, as stated on the short 
case studies of award winners and commended companies. Some examples are Chevron, 
Anglo American, Pfizer, Standard Chartered Bank and Accor hotels. 
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 Nonetheless, GBC has established measurable key outcomes for 20119, these relate 
much more to its organizational effectiveness and financial health than with actual health 
outcomes, and are the following:   
 
1. Membership revenue of 10% above 2011 budget 
2. Less than 5% unplanned employee turnover 
3. 20% increase in  revenue from Conference and Dinner (CAD) 
4. In addition to CAD and membership revenues, exceed 2011 general operating support 
revenue target by $300K  
5. Roll out of “new GBC” at CAD with clear mandate/mission/identity  




 The Coalition has already set some new goals for the near future, such as starting 
executive study tours, an affiliate membership program, increased Hong Kong and China 
networking, employee engagement programs, U.S. office of National AIDS Policy, US initiative 
expansion into Houston, a new Awards format. These are important and bold goals, 
particularly given the current economic environment. The financial crisis had a clear impact on 
GBC’s memberships in 2009/2010 and, consequently, on its budget. Though the Coalition was 
able to maintain all the impact initiatives other smaller and less urgent projects, still in the 
development process, were postponed. GBC also had to undertake some cuts in internal costs, 
as for instance not replacing positions and closing the offices in France and Ukraine. 
 GBC is determined in keeping its current business model, but being aware of its 
current financial challenges it is setting new income strategies. Apart from focusing in 
attracting new members and keeping current ones, the Coalition is finding out how to better 
appeal to companies through new price points (membership fees and corresponding services) 
and other types of membership. Also, GBC wants to bring in more revenue from sources other 
than membership fees. One of these sources will be an “experience” auction, with the help of 
its members GBC will offer experiences as for example a visit to a TV station. 
 But much more importantly, GBC will soon be repositioning with a new messaging 
around global health with a new name, new logo, and new vision and mission. As of June 2, 
                                                          
9 The financial goals stated are “stretch goals” grounded in concrete plans. They exceed revenue figures 
contained in the 2011 budget. 
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2011, at the 10th Anniversary Dinner and Conference, GBC on HIV/AIDS, Tuberculosis and 
Malaria will become GBCHealth and will have an extended mandate that will allow it to work in 
the whole spectrum of health issues, rather than only AIDS, TB and malaria.  These three 
diseases will continue to be the core of its work but the mandate will expand according to 
member interest and demand. As so, non-communicable diseases, such as diabetes, obesity 
and cardiovascular disease; will now be among the areas in which the Coalition can support 
company programs. It is expected that this change will help enlarge GBC’s membership 
significantly because there are many companies interested in health and wellness more 
generally that might now be attracted to join the Coalition. As a matter of fact companies like 
Intel and Dow Chemical have already joined the Coalition as a result of its announced mandate 
expansion. On the other hand GBC will stop working with the tobacco industry in order to be 
consistent with what it advocates – the new mandate includes diseases directly and 
irrevocably caused by tobacco’s consumption. GBC’s future mission and vision are: 
 Mission Statement: The mission of GBCHealth is to leverage the power and resources 
of the business community for positive impact on global health challenges. 
 Vision Statement: The vision of GBCHealth is a global business community that is fully 
contributing its assets, skills, influence and reach to making a healthier world for 
workers, their families and their communities.  
 
 But the question remains, given GBC’s evolution until today will these changes be 
enough to face the sustainability challenge derived from the current financial crisis? What does 
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Exhibit 1 – Information on HIV/AIDS, Malaria & TB 
 
HIV/AIDS 
 According to the World Health Organization (WHO), the acquired immune deficiency 
syndrome (AIDS) is caused by the human immunodeficiency virus (HIV), which attacks cells of 
the immune system, destroying or impairing their function. Individuals with AIDS have 
difficulty fighting infections, becoming easy targets to the so-called opportunistic diseases. 
 According to UNAIDS, in 2009 there were 2.6 million new HIV infections, this 
corresponds to 21% fewer cases than in 1997, when the number of new infections peaked. In 
33 countries (most in sub-Saharan Africa), the HIV incidence has fallen by more than 25% from 
2001 to 2009 (see Exhibit 2 - Changes in the incidence rate of HIV infection, 2001 to 2009, 
selected countries). Despite this decreasing trend, sub-Saharan Africa still accounts for the 
majority of new HIV infections. On the other hand, in some countries the number of new 
infections has increased more than 25%. In five Eastern Europe and Central Asia countries the 
number of people living with HIV has nearly trippled since 2000. 
 Globally, the number of AIDS-related deaths has decreased, from 2.1 million deaths in 
2004 (maximum ever) to about 1.8 million in 2009 (72% of which in sub-Saharan Africa).  This 
decreasing trend is due to a combination of factors, including HIV prevention efforts which led 
to a smaller incidence, and increased number of people undergoing treatment. But until today 
more than 25 million people have died from AIDS. 
 According to UNAIDS, in 2009 33.3 million people lived with HIV, against only 26.2 
million in 1999. This apparent discrepancy (27% increase) is explained by the fact that although 
less people are becoming infected there are also less deaths due to treatment, therefore 
increasing AIDS prevalence (see Exhibit 3 - Global prevalence of HIV, 2009). 
 According to GBC, 2 million people are expected to die this year for lack of access to 
treatment. The majority of those infected are of working age, making business directly related 
to them, for being either employees or their relatives. Business accountability can also be 
extended to the communities where it operates and their stakeholders. 
 Whichever way, business has definitely a major role in fighting HIV/AIDS. For every 
Coalition member, the motivation comes not only from saving lives, but also from protecting 
their interests by protecting their employees and their families, attracting and retaining talent 
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and earning their social license to operate. Some companies might even find new 
opportunities in markets at the bottom of the pyramid.  
 
Malaria 
 The WHO describes malaria as a disease caused by the Plasmodium parasite, which is 
transmitted to humans through the bites of infected mosquitoes. If left untreated, malaria can 
lead to death by impeding the blood supply to vital organs.  
 Nearly half of the world population lives in vulnerable areas (see Exhibit 4 - Malaria, 
countries or areas at risk of transmission, 2010), and though malaria is a preventable and 
curable disease, in 2009 there were still 225 million cases and 781,000 deaths caused by the 
disease. However, this represents a clear improvement compared with the 244 million cases in 
2005 and the 985,000 deaths in 2000. Malaria deaths occur mainly among children and in 
Africa they represent a fifth of all childhood deaths. 
 Although in all WHO Regions there has been a significant decrease in malaria cases, in 
2009 there has also been an increase in cases in Rwanda, São Tomé and Príncipe, and Zambia, 
countries that before were showing decreases. The biggest declines were observed in the 
European Region and the Region of Americas. Africa had the largest absolute decline in deaths.
 According to GBC malaria is a major threat to global health and economic welfare, it is 
responsible for employee absenteeism hence affecting productivity. The major challenges to 
fighting malaria are lack of resources and effectively implementing control activities, treatment 
and R&D. Business action is thus crucial in this fight, having the ability to go beyond bed nets 
distribution, to improve awareness, education, diagnosis and treatment components. 
 
Tuberculosis 
 According to the WHO, tuberculosis (TB) is an infectious bacterial disease caused by 
Mycobacterium tuberculosis.  It affects the lungs and, though treatable, can be potentially 
fatal. It is transmitted among humans through droplets from the throat and lungs of people 
with active TB.  
 In 2009 there were 9.4 million new TB cases and close to 2 million deaths. These 
numbers are generally the same each year, but in absolute terms TB incidence is actually 
increasing while in relative terms it decreasing about 1% each year. Currently, in low and 
middle-income countries TB is the eighth leading cause of death and third among adults aged 
15–59. 
 All countries show incidence of TB, but 30% of cases are in Africa and 55% in Asia (see 
Exhibit 5 - Estimated TB Incidence by Country, 2009). Most TB cases and deaths are in poor 
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countries, mostly because of health care issues – TB risk factors include higher exposure to 
unhealthy and crowded living and working environments, malnutrition, HIV infection, diabetes 
mellitus, smoking, alcohol and drug abuse. In fact TB is strongly related with HIV, individuals 
with HIV account for over 10% of TB cases every year and are much more likely to develop TB 
than those HIV-negative.  
 In addition, each year about 0.5 million cases are multidrug-resistant TB (MDR-TB), this 
form of TB has been increasing and has lower cure rates, between 50% and 70%.  
 TB’s impact on business is huge, the World Economic Forum estimates a resultant loss 
of $16 billion in countries’ annual incomes. Much like HIV/AIDS and malaria, TB leads to 






























Exhibit 4 - Malaria, countries or areas at risk of transmission, 2010 
 







Exhibit 5 - Estimated TB Incidence by Country, 2009 
 
Source: World Health Organization 
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Exhibit 6 – Key Financials 





















Income                         
     Contribution and grants $ 4,541,135 49.55% 5,163,924 45.73% -12.06% 4,004,952 37.92% 28.94% 468,010 7.56% 755.74% 
     Membership dues   2,927,000 31.94% 3,546,331 31.41% -17.46% 3,952,000 37.42% -10.26% 3,236,000 52.26% 22.13% 
     Special event revenue   1,263,502 13.79% 1,726,771 15.29% -26.83% 1,903,459 18.02% -9.28% 1,533,109 24.76% 24.16% 
     Donated goods and services 334,183 3.65% 769,050 6.81% -56.55% 529,628 5.01% 45.21% 806,912 13.03% -34.36% 
     Investment activity, net   42,935 0.47% -32,853 -0.29% -230.69% 108,520 1.03% -130.27% 98,815 1.60% 9.82% 
     Other income   55,589 0.61% 118,458 1.05% -53.07% 63,262 0.60% 87.25% 48,926 0.79% 29.30% 
                          
          Total Income   9,164,344 100% 11,291,681 100% -18.84% 10,561,821 100% 6.91% 6,191,772 100% 70.58% 
                          
Expenses                         
     Program services $ 7,057,163 77.74% 8,889,559 80.43% -20.61% 8,002,968 77.78% 11.08% 4,451,684 70.10% 79.77% 
     Supporting services   2,021,022 22.26% 2,162,616 19.57% -6.55% 2,285,650 22.22% -5.38% 1,898,632 29.90% 20.38% 
                          
          Total Expenses   9,078,185 100% 11,052,175 100% -17.86% 10,288,618 100% 7.42% 6,350,316 100% 62.02% 
                          
Change in Net Assets $ 86,159   239,506   -64.03% 273,203   -12.33% -158,544   -272.32% 
                          
                          
Notes: The values for 2002 are for the period September 10, 2001 (Commencement of Operations) to June 30, 2002. 
               The values for 2003 are for the year ended June 30, 2003. 
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Income                   
     Contribution and grants $ 468,010 7.56% 242,129 5.75% 93.29% 504,900 12.75% -52.04% 
     Membership dues   3,236,000 52.26% 2,514,500 59.69% 28.69% 2,453,500 61.94% 2.49% 
     Special event revenue   1,533,109 24.76% 1,129,485 26.81% 35.74% 647,500 16.35% 74.44% 
     Donated goods and services 806,912 13.03% 295,656 7.02% 172.92% 339,426 8.57% -12.90% 
     Investment activity, net   98,815 1.60% 30,614 0.73% 222.78% 15,282 0.39% 100.33% 
     Other income   48,926 0.79%       571 0.01% -100.00% 
                    
          Total Income   6,191,772 100% 4,212,384 100% 46.99% 3,961,179 100% 6.34% 
                    
Expenses                   
     Program services $ 4,451,684 70.10% 3,649,106 74.71% 21.99% 2,358,721 76.89% 54.71% 
     Supporting services   1,898,632 29.90% 1,235,481 25.29% 53.68% 708,910 23.11% 74.28% 
                    
          Total Expenses   6,350,316 100% 4,884,587 100% 30.01% 3,067,631 100% 59.23% 
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Income                 
     Contribution and grants $ 504,900 12.75% 25,000 1.15% 1,919.60% 991,457 50.44% -97.48% 
     Membership dues   2,453,500 61.94% 1,463,500 67.51% 67.65% 570,000 29.00% 156.75% 
     Special event revenue   647,500 16.35% 534,817 24.67% 21.07% 321,628 16.36% 66.28% 
     Donated goods and services 339,426 8.57% 141,019 6.50% 140.70% 82,581 4.20% 70.76% 
     Investment activity, net   15,282 0.39%             
     Other income   571 0.01% 3,650 0.17% -84.36%       
                    
          Total Income   3,961,179 100% 2,167,986 100% 82.71% 1,965,666 100% 10.29% 
                    
Expenses                   
     Program services $ 2,358,721 76.89% 944,776 64.64% 149.66% 511,828 76.83% 84.59% 
     Supporting services   708,910 23.11% 516,808 35.36% 37.17% 154,329 23.17% 234.87% 
                    
          Total Expenses   3,067,631 100% 1,461,584 100% 109.88% 666,157 100% 119.41% 
                    
Change in Net Assets $ 893,548   706,402   26.49% 1,299,509   -45.64% 
 
 














Exhibit 8 – Members by Industry and Region 2001/2011 
 
September 2001 
    Region     







Automotive - 1 - - 1 6% 
Biotech/Pharmaceutical - 1 - - 1 6% 
Construction/Machinery - - 1 - 1 6% 
Consulting - - - 1 1 6% 
Consumer Products - - 1 - 1 6% 
Energy (Oil, Gas & 
Electric) 
3 - 1 - 4 24% 
Financial/Bank/Insurance - - 1 1 2 12% 
Food & Beverages - 1 - - 1 6% 
Hotel/Travel/Tourism - - - 1 1 6% 
Industrial Manufacturing - - 1 - 1 6% 
Non-Corporate - 1 - 2 3 18% 
                
  Total 3 4 5 5 17   






    Region     







Agriculture - - - 2 2 1% 
Automotive - 1 1 6 8 4% 
Biotech/Pharmaceutical - 12 4 8 24 11% 
Chemical Manufacturing - 1 1 3 5 2% 
Computer/IT/Telecom - 5 1 3 9 4% 
Construction/Machinery - - - 4 4 2% 
Consulting 1 10 3 1 15 7% 
Consumer Products 1 10 2 6 19 8% 
Energy (Oil, Gas & 
Electric) 
2 3 2 5 12 5% 
Financial/Bank/Insurance 5 15 1 8 29 13% 
Food & Beverages 1 2 - 4 7 3% 
Healthcare/Medical - 2 1 3 6 3% 
Hotel/Travel/Tourism 2 5 - 5 12 5% 
Industrial Manufacturing 3 - 1 1 5 2% 
Legal Services - 2 - - 2 1% 
Media/Entertainment 2 15 1 5 23 10% 
Metals & Mining 4 4 2 6 16 7% 
Non-Corporate - 15 - 1 16 7% 
Public Relations - 4 2 1 7 3% 
Transportation Services - 1 - 2 3 1% 
Others 1 1 - - 2 1% 
                
  Total 22 108 22 74 226   
  % 10% 48% 10% 33%   100% 
 
















Exhibit 9 – GBC Member Companies by HQ location 
 









In the turn of the last century HIV/AIDS had vastly spread, gaining dramatic 
proportions and turning into the biggest and most significant 20th century pandemic. The 
impact of the disease on the world’s economy was evident. Nonetheless business did not seem 
to be paying much attention to health related problems and in practical terms was doing even 
less to tackle them.  
The Global Business Council was created in 2001, in the sequence of Nelson Mandela’s 
appeal for active action from the business community to fight the pandemic HIV/AIDS. Later 
that year U.S. Ambassador to the UN, Richard Holbrooke re-launched the Global Business 
Council as a Coalition with support from the UN Foundation, UNAIDS, and philanthropists Bill 
Gates (Gates Foundation), George Soros and Ted Turner. 
 From its inception, with just 17 member companies GBC has grown considerably and 
today it has 226 corporate and non-corporate members. The Coalition’s expansion model now 
includes captivating global health players, medium size enterprises and international NGOs. In 
2006 the focus of its mission also expanded to include diseases such as malaria and 
tuberculosis and in 2011 GBC’s mandate will extend to non-communicable diseases. 
 The Coalition joins forces with governments, international agencies and nonprofits to 
reach more people, more quickly, more effectively; its goal being to end these diseases more 
rapidly through collective actions for a common cause, which render greater impact. GBC 
guides companies through projects using their core competencies to maximize impact. 
 In the last 10 years a lot has changed, there has been great progress in the fight against 
HIV/AIDS, malaria and tuberculosis, and the business sector has not only increased its health 
related efforts but also taken them on from a more comprehensive perspective. GBC’s 
contribution to these changes has been immense. This is easily depicted from the results 
shown in terms of people reached with its initiatives. However, a better performance and 
impact measurement system is needed; a more systematic assessment of initiatives would 
help to further improve GBC’s effectiveness and impact. 
 Though until recently GBC had been consistently growing, with the global financial 
crisis new challenges appeared. Contrary to the tendency observed until then, for the first time 
the number of members suffered a decrease. Logically this had direct consequences on GBC’s 
budget (membership fees, contribution and grants) and the Coalition had to readjust 
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expenditures. The need to reduce costs might endanger the viability of much needed actions, 
and for this reason GBC is now looking for new ways to earn revenue and attract members 
while trying to keep their current memberships. 
   
Target Audience of the Case 
  
 This case is intended to be read by undergraduate or master students, specifically 
focused on the area of business management. It is of greater benefit if students already have a 




 Realize the importance of global health from a management perspective, given its 
impact in the global economy and businesses. 
 Understand the growing importance of CSR for companies’ sustainability and how it 
can become a source of competitive advantage if properly integrated in companies’ 
strategy (strategic CSR). 
 Familiarize with the existence of several different business models for social 
enterprises and their corresponding features. 
 Understand how financial crises affect CSR and the nonprofit sector - Students are 
encouraged to find creative solutions to overcome the obstacles posed to the 
nonprofit sector. 




 In the analysis of GBC’s case it is important to have a certain degree of conceptual 
knowledge about corporate social responsibility, the macroeconomics of health and 
sustainability in the nonprofit sector. The literature review presented above gives a summary 





Suggested Teaching Methods 
 
 The case should be given to students in advance in order for them to be able to 
carefully read it and analyze the major findings. Mentors could divide the discussion topics in 
order to have a more organized approach when analyzing the case. These topics could be given 
to students beforehand, to better prepare for class. In the class setting a summary of the case 
and the most relevant topics should be made. Having in mind the learning objectives, a set of 
questions is suggested for students to analyze the case, identify the key topics and relate them 
with their theoretical knowledge and life experiences when relevant.  
 Students should be divided in groups of 4 or 5 since smaller groups foster more 
interaction between classmates, allowing all of them to participate by sharing their opinion 
and interpretation of the case. Each group could be required to discuss between one and all 
topics, depending on the length of the class and whether groups were given the topics for 
discussion at home. Ideally, all of the main topics should be analyzed by each group.  
 After discussing the topics in-group their conclusions should be presented to the whole 
class. The mentor should organize and guide the session so that all groups are given the 
opportunity to share their perspective on the topics analyzed. For instance, each group would 
present a different topic, and then others would join the discussion, enriching it with their 
divergent or complementary views. 
 
Suggested Discussion Questions and Analysis 
 
1) Identify the role of health in human and economic development. How and to what 
extent does global health impact companies and the economy? 
 
- Healthy individuals can fully develop their intellectual, physical, social and emotional 
potential. They can also allocate their financial resources to others needs, therefore 
educational level and health are linked in two ways, mental ability and economic 
resources (Aguayo-Rico et al., 2005; Mexican Commission on Macroeconomics and 
Health, 2004; Sachs, 2001). 
- Figure 1 (Intergenerational Cycle of Human Capital Formation) in page 3 shows how a 
child’s health and education has future implications for the individual’s life, which are 
likely to affect and be passed on to the next generation. 
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- Figure 2 (Health as an Input into Economic Development) in page 5 illustrates the cycle 
and interdependency between health and economic development. 
- Disease prevents economic development mainly through (Sachs, 2001): 
 (1) Preventable diseases that reduce healthy life expectancy (workforce); 
 (2) Parents’ short investment in their children (basic needs and education); 
 (3) Undermining business returns and infrastructure investment (from workforce to 
clients and investors alienation).  
-  Cross-country studies show a positive relationship between health and economic 
growth. When life expectancy increases by 10% economic growth is expected to 
increase by 0.3% to 0.4% per year (Finlay, 2007; Sachs, 2001).   
- High incidence of diseases, such as malaria and HIV/AIDS, is also related to continuous 
and significant declines in economic growth rates. For instance malaria is known to 
reduce economic growth in at least 1% per year and a reduction of cases in only 10% 
would result in an increase of 0.3% in annual growth (Gallup & Sachs 2000 cit. in 
Mexican Commission on Macroeconomics and Health, 2004; Sachs, 2001). 
- Companies are mainly affected by health through their workforce productivity, 
absenteeism and turnover, with direct repercussions on their profitability. By affecting 
human development, health also influences individuals’ future income and wealth, 
impacting their buying power and therefore consumer market size. Plus, high 
prevalence of certain diseases might discourage tourism and otherwise lucrative 
investments (Aguayo-Rico et al., 2005; López-Casasnovas et al., 2005; Mexican 
Commission on Macroeconomics and Health, 2004; Sachs, 2001).  
 
2) How can CSR become a source of competitive advantage and influence companies’ 
sustainability? Are GBC’s members doing strategic CSR? How could the Coalition 
improve its strategic significance for member companies? 
 
- According to the triple bottom-line sustainability imperative, companies’ sustainability 
depends on three dimensions: economic, social and environmental. CSR acts directly 
on social and environmental dimensions, which also impact the economic dimension 
(Dhiman, 2008; Henderson, 2009). 
- Smith (2003) and Porter & Kramer (2006) argue that given the high market 
competitiveness, CSR can be a differentiation factor, creating a unique positioning and 
therefore a competitive advantage.  
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- Strategic CSR is the best way for companies to achieve competitive advantage. 
Strategic CSR is about applying companies’ capabilities on key actions that render 
maximum shared value - value for the companies and for society. Those capabilities 
are the most appropriate to deal with the problem at hand (Porter and Kramer, 2006).  
- Certain social issues will prove to have a significantly larger effect on a firm’s 
competitiveness, providing good opportunities for strategic CSR activities (Porter & 
Kramer, 2006). Figure 3 (Prioritizing Social Issues) on page 10 provides information on 
how to differentiate between these social issues. 
- GBC’s members are acting on social issues in the external environment that can have 
clear effects on their competitiveness (see Figure 3). Through their workplace disease 
prevention programs and other workplace initiatives, they are acting on major health 
issues that, as seen in question 1, directly influence their workforce productivity, 
absenteeism, and turnover and can even influence their market size through 
consumers’ buying power. On the other hand, if we take the example of certain impact 
initiatives to fight AIDS, while for some members they can be considered generic social 
issues (companies in other regions), for others it can be a value chain impact (like 
pharmaceutical companies) and finally it can be a competitive context issue for a 
company in the energy industry that relies on local labor for its operations. 
- Furthermore, for its impact initiatives, GBC seeks corporate collaboration among the 
companies that present the most suited core competencies to deal with the problem 
at hand and helps allocating their resources. As mentioned above, applying core 
competencies is a characteristic of strategic CSR. 
- GBC could improve its strategic significance for member companies by finding new and 
better ways to align its focus and initiatives with companies’ interests, this means 
focusing on health initiatives that are on the scope of companies’ value chain impacts 
and competitive context issues. In fact, this is precisely what GBC expects to do by 
expanding its mandate to health issues in general, Coalition’s members will thus be 
able to target other diseases that are more relevant to them and which can represent 







3) Identify the main business models for social enterprises and their most relevant 
features. How would you characterize GBC’s business model? Do you find it 
appropriate? 
 
- Traditional nonprofit model: The organization is completely dependent on external 
support, like philanthropy, voluntarism and government subsidy (Boschee & McClurg, 
2003; Elkington & Hartigan, 2008). Consequently they are neither sustainable nor self-
sufficient. 
- Leverage nonprofit model: Provide public goods to people economically vulnerable 
and at the same time allow them to assume ownership of the initiative, improving its 
long-term sustainability. The organization is supported by external entities financially, 
politically and in kind (Elkington & Hartigan, 2008). 
- Hybrid nonprofit model: Public goods are provided to those economically vulnerable 
but the organization also makes money and reinvests it. By selling goods or services 
the organization assures at least part of the costs it incurs in. It still seeks funds from 
public, private and philanthropic organizations. Such organizations are considered to 
be sustainable, even though they are not self-sufficient (Elkington & Hartigan, 2008). 
- Social business model: It is clearly a for-profit enterprise, but which focuses on social 
missions. Profits are spent supporting the poor and reinvesting to grow the venture. 
Investors do not simply give funding but actually seek both financial and social returns. 
The enterprise is not only sustainable but actually self-sufficient (Elkington & Hartigan, 
2008). 
- GBC’s income comes not only from external contributions but also from selling 
services (membership fees, annual conference & dinner and investment activities). 
This means that GBC embraces the hybrid nonprofit model, it is sustainable even if not 
self-sufficient. 
- Changing its business model to one of the first two mentioned would mean taking a 
step back, so the only consideration is whether GBC should change to a social business 
model or not. Given its mission, focus and objectives, such model does not seem to be 
appropriate; it does not seem to be truly aligned with the Coalition’s interests and 
values. In conclusion GBC’s business model is appropriate, but the organization could 






4) Recently the world has faced a significant financial crisis.  
4.1) What implications can we derive for companies’ CSR policies?  
 
- When companies face financial constraints one of the first things they must do is 
to cut those expenses believed to be superfluous. Unfortunately, CSR programs 
are among the first to be cut, or at least to see their budget significantly reduced. 
Smith (2003) correlates the ups and downs of interest in CSR with economic 
prosperity and recession, respectively. 
- Therefore, it can be derived that only when companies’ CSR practices are truly 
integrated in their strategy and seen as an important source of sustainability and 
competitive advantage is it more likely that CSR budget is maintained or cuts kept 
to a minimum. 
 
4.2) Analyze GBC’s key financials (Exhibit 6). How were GBC’s budget, activities and 
structure affected by the crisis? In your opinion, what could GBC do to minimize 
the effects of the crisis and better cope with the new challenges? 
 
- From the beginning of operations GBC’s total income had always observed a 
double digit annual growth rate, the only exception being 2005 with a mere 6.34% 
growth rate, mostly due to a decline of more than 50% in contributions and grants. 
A similar income growth rate (6.91%) was not seen until 2008, when the 
consequences of the financial crisis were felt for the first time. In an 
unprecedented shift, revenues from membership dues has a negative growth, this 
means that companies leaving GBC outnumbered those entering. A lot of money 
was also lost in investment activity. However, 2009 was definitely the worse year 
for GBC, with every income item having negative growth. GBC had experienced its 
first ever negative income growth rate. 
- Total expenses growth rate normally followed income tendencies. Even in 2008 
and 2009 GBC was able to manage and cut expenses and end the year with a 
positive balance. Only in 2005 and 2006 did expenses surpass income. 
- Data shows that in its first year of activity half of GBC’s income came from external 
support. This was significantly reduced in the following years, when GBC’s earned 
revenue accounted for far more than half of its income. However, in 2007 the item 
“contributions and grants” increased its relative weight from a small 7.56% to 
nearly 38%. In 2008 and 2009 this item represented almost 50% of income (note 
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that in 2009 its absolute value even decreased). Clearly it has been more difficult 
for GBC to keep its earned revenue. 
- When looking at expenses, the Coalition has always been very consistent – the 
majority of the money goes to program services, with a small percentage, of 
maximum one third of expenses, going to supporting services. These numbers 
suggest that most of the money is being spent in the planning and implementation 
of actions/programs; and only a small amount in fundraising, management and 
general expenses. The financial crisis did not affect the relative distribution of 
money spent, even though it affected expenses since cuts had to be made. 
- GBC’s reduced budget meant cutting expenses. Though impact initiatives were not 
affected by these cuts, other less urgent and smaller projects had to be postponed. 
Furthermore, some internal rearrangements had to be undertaken. For instance, 
the Coalition closed its offices in Paris and Kiev, and established a strategic alliance 
with the European social enterprise Local InSight Global Impact. Another example 
is that it also stopped replacing positions. 
- Some suggestions for coping with the new challenges are trying to find new ways 
to improve its earned revenue (new income sources); improving its strategic 
significance for member companies, which would help keeping and attracting new 
members; and trying to improve programs’ performance measurement, this would 
be important for two reasons – better allocation of resources, to the activities that 
prove to be most effective and have best results; and positively influence potential 
members, by showing how their services positively impact member companies’ 
performance, namely through their productivity, social reputation and brand 
image. Though GBC does not control companies it can try to provide further 
incentives for implementing programs’ performance measurement and 
assessment. 
- GBC’s future directions seem consistent with the first two suggestions. With the 
help of its members GBC will start offering and earning revenue from an 
“experience” auction. Also, the Coalition is soon going to expand its mandate to 
health, which means that it will be providing services related with other diseases – 
this will improve their attractiveness to other potential members whose main 
concerns do not relate so closely to HIV/AIDS, malaria and tuberculosis but with 
other diseases. Moreover, GBC is trying to find new price points for membership 
fees and services offered, therefore becoming more appealing to companies that 
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are only interested in certain specific services or that cannot afford or are 
unwilling to pay the existent current fees. 
 
5) Based on the data provided (see Exhibit 8), what would you say were the most 
relevant changes in GBC’s membership base? What future changes/trends would 
you expect? Explain your reasoning. 
 
- When comparing GBC’s status in September 2001 to April 2011 two aspects stand out 
immediately: one is the number of members that increased from just 17 to 226 
companies; and the other is the number of industries represented, when initially there 
were only 11 today there are more than 20. These two factors not only establish GBC’s 
impressive growth in a decade, especially taking into consideration the impact of the 
global financial crisis, but they are also important from a qualitative perspective since 
their diversity reflects a multiplicity of core competencies that can be used in different 
programs according to their relevance. 
- Today all regions have an increased number of members, in particular the Americas 
and Europe augmented their presence immensely, from 4 to 108 members and from 5 
to 74 members respectively. Africa and the Asia/Pacific regions currently have only 22 
members each, despite being the regions most affected by HIV/AIDS, malaria and TB. 
Such discrepancy might be related with the fact that these are also poorer regions, and 
has mentioned in the literature CSR seems to be related with economic prosperity, 
with recessions leading to a disinvestment in this area (Smith, 2003). As so, the 
evidence shown is in line with the literature and it seems reasonable to assume that 
lower-income countries (Africa and Asia/Pacific) are less likely to invest in CSR, and 
higher income-countries (Americas and Europe) more likely to do so. 
- Concerning the relative weight of industries represented, those that stand out are 
Biotech/Pharmaceutical, Financial/Bank/Insurance and Media/Entertainment. These 
industries, perhaps only with the exception of the latter, are those that normally have 
worse social perception and reputation. They are strongly associated with greed, with 
wanting to make money at any cost, not caring for those affected by their actions. 
Pharmaceuticals, for instance, are well known for the role played in the AIDS pandemic 
in Africa, when they initially created numerous obstacles to drugs distribution for 
patent related reasons (endangering the social dimension of the triple bottom-line 
sustainability imperative). The financial industry is also strongly related to capitalism 
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and frequently blamed for the role played in financial crises and the associated 
corporate scandals. Ten years ago the sectors with strongest presence were Energy 
(Oil, Gas & Electric), Financial/Bank/Insurance and Non-Corporate. The energy sector 
also falls in the category of the two others just described (jeopardizing both the social 
and environmental dimension of the triple bottom-line sustainability imperative), and 
the non-corporate sector by its own nature seems to be more prone to social 
concerns. 
- Regarding membership’s future trends, though its current trend has been a decline in 
the sequence of the global financial crisis, it is expected to increase in the short-term 
for two central reasons: GBC’s mandate expansion and new price-points that will most 
likely attract new members; and the significant economic growth evident in some 
previously lower-income countries (Africa and Asia/Pacific), their new economic 
prosperity will likely increase the investment made in CSR, which might bring new 
members for the Coalition – based on Smith (2003) observation of increasing interest 





 On the whole this case study provides a good and comprehensive perspective of GBC 
in terms of its past, present and future. Some of the problems and challenges the organization 
is experiencing might even apply to other social enterprises. The nonprofit sector in particular 
is very likely being affected by similar issues. GBC has proved to be in the right track to 
reposition itself and regain its prior financial sustainability. Despite the outcomes of the 
strategy that already is or will soon be implemented are yet to unveil, some of these ideas can 
be adopted and adapted by other organizations to their own reality. 
 This study has accomplished its aim, expressed in the problem statement. The case 
study and its analysis show not only the different dimensions affected by the financial global 
crisis and the extent of its impact, but also how this impact might evolve in the future. The 
research questions helped guide the case study analysis towards the aim of this work, and are 
therefore also a good starting point for reaching conclusions. GBC will soon be expanding its 
mandate and mission to global health, this is one factor that will help secure its membership 
basis, since it will become more appealing to more companies given the bigger alignment in 
interests. Another factor is the creation of new price-points, becoming affordable to more 
companies; and finally the economic growth observed in previously lower-income countries 
that are greatly affect by diseases like HIV/AIDS, TB and malaria. 
 Secondly, GBC’s budget was significantly reduced after the crisis. GBC had to cut 
expenses, which lead to the closure of two offices in Europe. The coalition undertook several 
internal rearrangements but managed to secure the execution of its high impact initiatives. 
Though smaller scale activities might have been jeopardized, the crisis fortunately did not 
affect the larger scale, globally more relevant actions. 
 Finally, GBC’s sustainability, with the help of some new directions and income sources, 
seems not to be at stake. With its current business model though GBC is not self-sufficient, it is 
sustainable. This is of the utmost importance given the work they develop and the good results 
that have had so far. Health truly is an important asset for human development and also a 
relevant factor for economic growth and prosperity. Improvements to GBC’s business model 
are needed and have to be undertaken (new income sources) but further, more substantial 
change is unnecessary.  
 This study has had some limitations.  Considerations regarding the appropriateness of 
the data used and its subsequent analysis are important to be made. The 2010 financial 
statements were not yet available, which means that the financial analysis is not totally up-to-
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date and new trend shifts could already exist. Similarly, despite the effort made in order to 
include the most recent and even information on the future of the organization, a lot of the 
data provided and analyzed will soon be outdated given the repositioning the Coalition will 
very soon be undertaking. Moreover, information regarding memberships by year (between 
2001 and 2011) could not be collected. This would have been important to understand more 
thoroughly how members evolved in terms of quantity, industry and region, and try to 
establish relationships and possible causes for the trends observed. It would also have allowed 
quantifying precisely the decrease in GBC’s members after the crisis and characterizing the 
industries and regions most affected. 
 When analyzing the case study there is one area that stands out for falling short of its 
needs and the difficulty in addressing it: evaluation and performance measurement. This is one 
of the major issues for effectiveness, efficiency and progress. Given its relevance for the future 
of GBC and any other company, future research on this matter is suggested. This is especially 
important given the difficulty in mobilizing and convincing companies to engage in these 
practices that can help render better results in the long-term. As so, two main points are 
highlighted, one is how to evaluate the programs (procedures, etc) and the other is the most 
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